UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients Genetics Investing
Cynata Therapeutics Completes Patent Application to Cover Cymerus Stem Cell Technology Genetics Investing
OpGen Completes Rapid Testing Clinical Trial in Colombia and Expands International Operations Genetics Investing
Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa Genetics Investing
Mesoblast Clinical Program Update for MPC-150-IM in Patients With Chronic Heart Failure Genetics Investing
Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series Products That Provide Automated, Closed System Cellular Processing Biotech Investing
CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018 Genetics Investing
New Preclinical Studies Reinforce the Potential for Heightened Anti-Cancer Activity of Combination Therapies Based on Immunovaccine’s Proprietary Delivery Platform Biotech Investing
Cancer Genetics’ Unique Tissue of Origin Test Receives Special FDA 510(k) Clearance Genetics Investing